乙基(2R)-2,3-环氧树脂丙烷酸酯 | 111058-33-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 环氧化物
• 中文名称: 乙基(2R)-2,3-环氧树脂丙烷酸酯
• 中文别名: (R)-环氧乙烷羧酸乙酯；(2R)-缩水甘油酸乙酯；(2R)-2,3-环氧丙酸乙酯；乙基(2R)-2,3-环氧丙酯
• 英文名称: ethyl (R)-(+)-2,3-epoxypropanoate
• 英文别名: Ethyl (2R)-2,3-epoxypropanoate；ethyl (2R)-oxirane-2-carboxylate
• CAS: 111058-33-4
• 化学式: C₅H₈O₃
• 分子量: 116.117
• InChiKey: LSGWSXRILNPXKJ-SCSAIBSYSA-N

物化性质

• 沸点：
  68-69 °C (15 mmHg)
• 密度：
  1.180±0.06 g/cm3(Predicted)
• 闪点：
  45 °C
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xn
• 危险类别码：
  R22
• 安全说明：
  S16
• 包装等级：
  III
• 危险类别：
  3
• 危险性防范说明：
  P210,P233,P240,P241+P242+P243,P264,P280,P302+P352+P332+P313+P362+P364,P305+P351+P338+P337+P313,P403+P235,P501
• 危险品运输编号：
  1993
• 危险性描述：
  H225,H315,H319
• 储存条件：
  存于0至6℃阴凉干燥处密封保存。

SDS

Name:	Ethyl (2r)-2 3-epoxypropanoate 97% Material Safety Data Sheet
Synonym:	(R)-(+)-Ethyl glycidate; (+)-Ethyl (2R)-oxiranecarboxylat
CAS:	111058-33-4

Section 1 - Chemical Product MSDS Name:Ethyl (2r)-2 3-epoxypropanoate 97% Material Safety Data Sheet
Synonym:(R)-(+)-Ethyl glycidate; (+)-Ethyl (2R)-oxiranecarboxylat

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
111058-33-4	Ethyl (2R)-2,3-epoxypropanoate, 97%	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical aid if cough or other symptoms appear.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 111058-33-4: Personal Protective Equipment Eyes: Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear a chemical apron.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Clear
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 68 - 69 deg C @ 15.00mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H8O3
Molecular Weight: 116.11

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 111058-33-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl (2R)-2,3-epoxypropanoate, 97% - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 111058-33-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 111058-33-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 111058-33-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  乙基(2R)-2,3-环氧树脂丙烷酸酯 在 二甲基硫 、 N,N-二异丙基乙胺 、 copper(I) bromide 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 (R)-(+)-(methoxy-2 ethoxymethoxy)-2 methyl-5 hexene-4 oate d'ethyle
  参考文献：
  名称：

  Larcheveque, Marc; Petit, Yves, Bulletin de la Societe Chimique de France, 1989, # 1, p. 130 - 139

  摘要：

  DOI：
• 作为产物：
  描述：

  (R)-环氧乙烷-2-羧酸钾 生成 乙基(2R)-2,3-环氧树脂丙烷酸酯
  参考文献：
  名称：

  LARCHEVEQUE, MARC;PETIT, YVES, BULL. SOC. CHIM. FR.,(1989) N, C. 130-139

  摘要：

  DOI：

文献信息

• [EN] NOVEL ANTIMICROBIAL ARYLOXAZOLIDINONE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES D'ARYLOXAZOLIDINONE ANTIMICROBIENS
  申请人：WARNER LAMBERT CO

  公开号：WO2005019214A1

  公开（公告）日：2005-03-03

  Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial agents. They are especially active against aerobic Gram-negative organisms. The compounds have the following structure: or a pharmaceutically acceptable salt thereof wherein: “---”is a bond or is absent; A is a structure selected from the group consisting of i, ii, iii, and iv wherein “---” is a bond or is absent and “~~~” indicated points of attachment; and the other variables are defined in the description

  公式（I）的化合物及其制备方法已被披露。进一步披露了制备公式（I）生物活性化合物的方法，以及包含公式（I）化合物的药用可接受组合物的方法。如本文所披露的公式（I）化合物可用于各种应用，包括用作抗菌剂。它们对需氧革兰氏阴性微生物特别活跃。这些化合物具有以下结构：或其药用可接受盐，其中：“---”是键或不存在；A是从i、ii、iii和iv组成的结构中选择的结构，其中“---”是键或不存在，“~~~”表示连接点；其他变量在描述中定义。
• Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
  申请人：——

  公开号：US20040014967A1

  公开（公告）日：2004-01-22

  The present invention is directed to novel amide-containing compounds which have an improved solubility and a method of improving the solubility of amide-containing compounds. The amide-containing compounds include oxazolidinone compounds and the bioavailability of these oxazolidinone compounds is improved by improving the solubility thereof.

  本发明涉及具有改善溶解性的新型酰胺化合物，以及改善酰胺化合物溶解性的方法。这些酰胺化合物包括噁唑烷酮化合物，通过改善其溶解性来提高这些噁唑烷酮化合物的生物利用度。
• N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
  申请人：——

  公开号：US20040147760A1

  公开（公告）日：2004-07-29

  The present invention provides antibacterial agents having the formulae I, II, and III described herein.

  本发明提供了具有以下式I、II和III的抗菌剂。
• [EN] SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME<br/>[FR] INHIBITEURS SÉLECTIFS DE L'INFLAMMASOME NLRP3
  申请人：NODTHERA LTD

  公开号：WO2019025467A1

  公开（公告）日：2019-02-07

  The present disclosure relates to compounds of Formula (I): (I); and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as autoinflammatory and autoimmune diseases and cancers.

  本公开涉及式(I)化合物：(I)；及其药用可接受盐、药物组合物、使用方法和制备方法。所公开的化合物可用于通过抑制炎症小体来抑制IL-1家族细胞因子的成熟，并可用于治疗炎症小体活性涉及的疾病，如自炎性和自身免疫疾病以及癌症。
• [EN] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS<br/>[FR] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES ET LEURS DERIVES ET UTILISATION DE CES COMPOSES COMME ANTIBACTERIENS
  申请人：UPJOHN CO

  公开号：WO2003072553A1

  公开（公告）日：2003-09-04

  Compounds of formula B-C-A-CO-NH-R1, wherein A is structure i, ii or iii: formulae (I), (II), (III). C is optionally substituted aryl or heteroaryl, and B is a specified cyclic moiety, or C and B together are a heterobicyclic moiety, are useful as antibacterial agents.

  公式为B-C-A-CO-NH-R1的化合物，其中A是结构i、ii或iii：公式(I)、(II)、(III)。C是可选择取代的芳基或杂环芳基，而B是特定的环状基团，或者C和B一起是一个杂双环基团，可用作抗菌剂。